Salpingectomy for Sterilization

Similar documents
Female Sterilization. Kavita Nanda, MD, MHS FHI 360 Expanding Contraceptive Choice December 6, 2018

According to the most recent data (2011

Contents Introduction. Recommendations at a Glance. Introduction. Background. Clinical Recommendations

Christine Garcia, MD 1, Liisa Lyon, MS 2, Ramey D. Littell, MD 1 and C. Bethan Powell, MD 1

Christine Herde, MD, FACOG

MEDICAL POLICY SUBJECT: FEMALE STERILIZATION. POLICY NUMBER: CATEGORY: Contract Clarification

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

PRETREATMENT ASSESSMENT & MANAGEMENT (MODULE 1 B) March, 2018

Key Recommendations. Gynecologic management of women with inherited risk of gynecologic cancer

Opportunistic Risk Reduction Salpingectomy and Ovarian Cancer

Key Recommendations. Gynecologic management of women with inherited risk of gynecologic cancer. HBOC related genes. I have nothing to disclose

Gynecologic Quality Measures. David M. Jaspan, DO FACOOG Chairman The Department of Obstetrics and Gynecology The Einstein Healthcare Network

da Vinci Hysterectomy Overview Hysterectomy Facts

Instruction for the patient

Laparoscopic Salpingectomy for Ectopic Pregnancy Simulation

Birth Control- an Overview. Keith Merritt, MD. Remember, all methods of birth control are safer and have fewer side effects than pregnancy

A Study on Tubal Recanalization

Both type I and type II tumors develop from extraovarian tissue that implants on the ovary. Both for LGSC and HGSC, the fallopian tube appears to be

Gyn Define Gyn at Dictionary British Dictionary definitions for gyngyn combining form variant of gyno What Is an OB GYN Healthline Medical

improved with an MIS approach. This clinical benefit for American women has been demonstrated with Level I evidence. Hysterectomy is one of the most

Gynecology Oncology Rotation

Accreditation Council for Graduate Medical Education

Robot-Assisted Gynecologic Surgery. Gynecologic Surgery

Partners: Introductions: Dr. Carolyn Johnston Deanna Cosens & Ann Garvin. Ovarian Cancer and Primary Care July 16, :00 9:00am EST 7/16/2014

Lindsey Tingen, MD Department of Obstetrics and Gynecology, Greenville Health System Greenville, SC

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

CURRICULUM VITAE. Steven G. Bernstein, M.D. 718 Kessler Lake Drive Dallas, TX (214)

Disclosures/Conflict of Interest. Learning Objectives 10/2/2015. Opportunistic salpingectomy for ovarian cancer prevention Jessica N McAlpine, UBC

University Gynecologic Oncology Associates

Chronic Pelvic Pain. Bridget Kamen, MD Obstetrics and Gynecology, Confluence Health. I have no disclosures

Research Article Body Mass Index and Its Role in Total Laparoscopic Hysterectomy

OVARIAN CANCER Updates in Screening, Early Detection and Prevention

Index. B Bladder, injury of, Bowel, injury of, , Brachytherapy, for cervical cancer, 357 Burns, electrosurgical,

An analysis of the impact of previous laparoscopic hysterectomy experience on the learning curve for robotic hysterectomy

Safety communications warning against use of power

Cost-benefit analysis of state and hospital funded postpartum intrauterine contraception for recent immigrants to the United States

CURRICULUM VITAE. Steven G. Bernstein, M.D Walnut Hill Lane Suite 316 Dallas, Texas (214)

CLINICAL GUIDELINES ID TAG Female Sterilisation (tubal occlusion) at Caesarean Section- Guideline for counselling and consent

Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization

I have no financial interests in any product I will discuss today.

FRANZCOG Training Program Logbook Procedure List and Classification

BRCA mutation carrier patient: How to manage?

Ovarian, Peritoneal, and Fallopian Tube Epithelial Cancer (OPT)

Medicaid Family Planning Waiver Services CPT Codes and ICD-10 Diagnosis Codes

I have no financial interests in any product I will discuss today.

Dipartimento Materno-Infantile Direttore : Paolo Puggina. Miomectomia laparoscopica indicazioni e limiti Giuseppe De Francesco

Malcolm L. Margolin, M.D. OB/Gyn

Public perception of risk-reducing salpingectomy for preventing ovarian cancer

Case Report The Actual Role of Surgical Therapy for Ectopic Pregnancy. Evaluation of laparoscopic and laparotomic surgery in tubal pregnancy

Permanent Sterilization: When you are really sure!

Results of microsurgical reconstruction in patients with combined proximal and distal tubal occlusion: double obstruction

POST HYSTERECTOMY HEMATOCRIT:

Screening in Ovarian Cancer: Any closer to the Holy Grail?

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.017.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2016

CODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40

Unexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine

October 9, Dear Ms. Chowdhury:

Clinical Study Changing Trends in Use of Laparoscopy: A Clinical Audit

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES

Family Planning Eligibility Program

Cpt code for removal of pelvic mass

The Effect of Catholic Hospitals on Rates of Postpartum Sterilization in California and Texas

4) Nezhat FR, Apostol R, Mahmoud M, El Daouk M. Malignant transformation of endometriosis and its clinical significance. Fertil Steril 2014 [In Pess]

Long-Term Health Outcomes of Surgical Menopause

M-AFRAKHTEH. MD OCT.2017 SHOHADA HOSPITAL TAJRISH

SCREENING FOR OVARIAN CANCER DR MACİT ARVAS

What You Need to Know About Ovarian Cancer

Gynecologic. Indiana Regional Medical Center Procedures to Labs/Tests June 1, A/P REPAIR W/SACROSP COLPOPEXY Table 1

Addressing The Gynecologic Oncology

Contents SECTION I: ESSENTIALS OF LAPAROSCOPY. Chapter 1: Chronological advances in Minimal Access Surgery

ABSTRACT. KEY WORDS antibiotics; prophylaxis; hysterectomy

Salpingo(s)tomy versus salpingectomy for tubal pregnancy; impact on future fertility

Privileges for: Obstetrics and Gynecology

Ovarian Cancer. Georgia McCann, MD. Division of Gynecologic Oncology

Carolyn Westhoff, M.D., and Anne Davis, M.D. INCIDENCE AND PREVALENCE

Factors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage

OB HEMORRHAGE: CARTS, KITS AND TRAYS

KAISER PERMANENTE ANNUAL CANCER REPORT 2016 MEDICAL CENTER SAN FRANCISCO THE PERMANENTE MEDICAL GROUP COMMISSION ON CANCER COMMITTEE DECEMBER 2016

Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207

LIE GREAT IMPORTANCE of the tubal factor in the etiology of female

Pregnancy outcome following microsurgical fimbrioplasty

Management of Endometrial Hyperplasia

L 3 -ObGyn TM for OB/GYN Residents

Updates in Gynecologic Oncology. Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018

Log Title: OBRES Gynecologic Case Log

CHAPTER 13 Gynaecological Procedures

Atlas Of Gynecologic Surgical

Core Module 7: Surgical Procedures

Hysterectomy Fact versus fiction. Richard Dover Specialist Gynaecologist

Minimally Invasive Gynecologic Surgery Rotation Royal Victoria Hospital and Jewish General Hospital

SCIENTIFIC PAPER ABSTRACT INTRODUCTION MATERIALS AND METHODS

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

OUTCOMES OF ROBOTIC, LAPAROSCOPIC AND OPEN ABDOMINAL HYSTERECTOMY FOR BENING CONDITIONS IN OBESE PATIENTS

I have no financial interests in any product I will discuss today.

Clinical Study Initial Experience with Robotic Retropubic Urethropexy Compared to Open Retropubic Urethropexy

Hereditary Gynecologic Cancer 15 Years of Progress

HEDIS QUICK REFERENCE GUIDE: DOCUMENTATION TIPS FOR ADULT MEASURES

Schedule of Benefits. for Professional Fees Gynaecology

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Transcription:

Salpingectomy for Sterilization Change in Practice in a Large Integrated Health Care System 2011-2016 Journal Club November 15, 2017 Blaine Campbell, DO

Salpingectomy for Sterilization: Change in Practice in a Large Integrated Health Care System, 2011-2016 C. Bethan Powell MD et all Obstetrics and Gynecology, 130: 961-967 November 2017 From the Kaiser Permanente Northern California Gynecologic Cancer Program San Francisco, Kaiser Permanente Northern California Division of Research Oakland, Kaiser Permanente OBGYN Residency Program San Francisco, and the Division of Gynecologic Oncology at the University of Virginia, Charlottesville, VA

Background Evidence supports the fallopian tube as the potential site of origin for some ovarian cancers In 2013, the Kaiser Permanente Northern California group published a policy statement recommending salpingectomies for surgical tubal sterilization at the time of hysterectomy Society of Gynecologic Oncologists (SGO) and American College of Obstetricians and Gynecologists (ACOG)

By performing salpingectomy in operation in which the fallopian tubes could be removed the risk of ovarian cancer may be further reduced. Randomized controlled trials are needed to support the validity of this approach. Other than a significant increase in operative time no significant differences in operative times or complication rates for salpingectomy have been identified. For women at population risk (average) for ovarian cancer, salpingectomy should be considered (after completion of childbearing) at the time of hysterectomy, in lieu of tubal ligation, and also at the time of other pelvic surgery. The pathologic specimen processing in low risk women should include representative sections of the tube, any suspicious lesions, and entire sectioning of the fimbriae.

Materials and Methods Retrospective cohort study, including 10,741 total cases PRIMARY OBJECTIVE Evaluate utilization of salpingectomy for tubal sterilization in the cesarean, postpartum, and interval settings from 2011-2016 SECONDARY OUTCOMES Blood loss Operating time Length of stay Readmission rates within 30 days ER visits within 7 days

Materials and Methods INCLUSION CRITERIA Age >18 years old Surgical database ( tubal occlusion, ligation, fulguration, salpingectomy, cesarean ) EXCLUSION CRITERIA Hysterectomy Procedure involving oophrectomy Diagnosis of ectopic pregnancy Personal history of ovarian cancer, BRCA1/BRCA2, or Lynch mutation

Materials and Methods Salpingectomy Occlusion procedures: clips, rings, fulguration, partial salpingectomy, and cutting/suture interruption as previously described by Westberg et al Most were bipolar, monopolar, or suture Other information collected: Age, race, parity, neighborhood poverty level, BMI Medical center surgery was performed, OR time, postop stay, EBL Readmissions and ER visits used as markers of complications

Materials and Methods Peripartum: performed at time of cesarean and within 3 days of vaginal delivery Cesarean and postpartum Interval: all other procedures Concurrent procedures: performed with any other major procedure (ex: cholecystectomy, ovarian cystectomy, appendectomy); minor procedures not included (cervical biopsies or EMB) Information broken down in 1-year intervals X 2 and Fisher exact tests

Results PRIMARY OUTCOME: Evaluate utilization of salpingectomy for tubal sterilization in the cesarean, postpartum, and interval settings from 2011-2016 Increase in utilization of salpingectomy as method of sterilization for interval sterilization but not for peripartum period

Results SECONDARY OUTCOMES: (salpingectomy vs tubal occlusion) Blood loss Cesarean: 700ml vs 660ml (P = 0.24) Postpartum: 250ml vs 200ml (P = 0.04). Interval: 5ml for both (P = 0.65) Operating time Cesarean: 9.5 minutes longer (P = <0.001) Postpartum: 17 minutes longer (P = 0.003) Interval: 3 minutes longer (P = <0.001)

Results SECONDARY OUTCOMES: (salpingectomy vs tubal occlusion) Length of stay no statistically significant change Readmission rates within 30 days no statistically significant change ER visits within 7 days no statistically significant change

Discussion ACOGs recommendation, SGO recommendation Practice similar to WMC prior to release of material Most tubals were occlusive by bipolar, monopolar, and suture Meticulous about data to ensure numbers were correct for each procedure Coding of procedures and checking pathology reports Considering another major procedure at same time as sterilization Distinguishing between procedure types Numbers Broke down data to cesarean, postpartum, and interval tubals for interpretation and utilization into one s own practice

Questions and Comments

Thank you